

Biocomposites
"Engineers calcium compound devices for infection management in bone and soft tissue"
About Biocomposites
Biocomposites engineers, manufactures and markets calcium compound devices that manage infection in bone and soft tissue. Products like STIMULAN, an absorbable calcium sulfate antibiotic carrier, and SYNICEM bone cements address osteomyelitis, periprosthetic joint infections, and infected non-unions. Over 500 specialists support surgeons across orthopaedics, trauma, spine, and podiatry in 100+ countries. Thirty years of expertise in calcium salts and medical polymers delivers solutions where conventional treatments fall short. Each device carries antibiotics directly to infected sites or regenerates bone naturally. One million procedures per year rely on these tools to treat diabetic foot infections, open fractures, and spinal infections.


560
Team Members
1997
Founded
Private Equity
Funding
Hybrid
Work Environment
A world where bone infection is manageable, treatable, and no longer limits recovery or quality of life for patients facing musculoskeletal trauma and disease.
Biocomposites transforms outcomes and changes patients' lives through engineering and manufacturing products for infection management and bone regeneration.